Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

SYN

Synthetic Biologics (SYN)

Synthetic Biologics Inc
일자:
정렬 기준:
 검색 관련기사 보기:AMEX:SYN
일자시간출처헤드라인심볼기업
2021/01/0106:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:SYNSynthetic Biologics Inc
2021/01/0106:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:SYNSynthetic Biologics Inc
2020/12/2221:00PR Newswire (US)Synthetic Biologics Announces Washington University School of Medicine in St. Louis IRB Approval of the SYN-004 (ribaxamase) ...AMEX:SYNSynthetic Biologics Inc
2020/11/2421:00PR Newswire (US)Synthetic Biologics Announces Extension of Compliance Plan Period by NYSE AmericanAMEX:SYNSynthetic Biologics Inc
2020/11/1820:04Edgar (US Regulatory)Current Report Filing (8-k)AMEX:SYNSynthetic Biologics Inc
2020/11/1807:25Edgar (US Regulatory)Current Report Filing (8-k)AMEX:SYNSynthetic Biologics Inc
2020/11/1807:25Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)AMEX:SYNSynthetic Biologics Inc
2020/11/1621:00PR Newswire (US)Synthetic Biologics Engages A.G.P./Alliance Global Partners as Advisor to Assist in Evaluating Strategic OptionsAMEX:SYNSynthetic Biologics Inc
2020/11/1305:40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:SYNSynthetic Biologics Inc
2020/11/1305:40Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:SYNSynthetic Biologics Inc
2020/11/1221:00PR Newswire (US)Synthetic Biologics Welcomes Senior Biotech Executive John Monahan, PhD, to Board of DirectorsAMEX:SYNSynthetic Biologics Inc
2020/11/1107:01Edgar (US Regulatory)Quarterly Report (10-q)AMEX:SYNSynthetic Biologics Inc
2020/11/1106:21Edgar (US Regulatory)Current Report Filing (8-k)AMEX:SYNSynthetic Biologics Inc
2020/11/1106:15PR Newswire (US)Synthetic Biologics Reports 2020 Third Quarter Operational Highlights and Financial ResultsAMEX:SYNSynthetic Biologics Inc
2020/11/0406:30PR Newswire (US)Synthetic Biologics to Report 2020 Third Quarter Operational Highlights and Financial Results on November 10, 2020AMEX:SYNSynthetic Biologics Inc
2020/10/2906:24Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)AMEX:SYNSynthetic Biologics Inc
2020/10/0220:00PR Newswire (US)Synthetic Biologics Provides Update on Investigator-Sponsored Phase 2b Clinical Study of SYN-010 in IBS-C PatientsAMEX:SYNSynthetic Biologics Inc
2020/09/1820:01Edgar (US Regulatory)Current Report Filing (8-k)AMEX:SYNSynthetic Biologics Inc
2020/08/0705:23Edgar (US Regulatory)Current Report Filing (8-k)AMEX:SYNSynthetic Biologics Inc
2020/08/0705:15PR Newswire (US)Synthetic Biologics Reports 2020 Second Quarter Operational Highlights and Financial ResultsAMEX:SYNSynthetic Biologics Inc
2020/08/0506:02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:SYNSynthetic Biologics Inc
2020/07/3020:00PR Newswire (US)Synthetic Biologics Announces FDA Clearance of Investigational New Drug Application for SYN-020 Intestinal Alkaline Phosphata...AMEX:SYNSynthetic Biologics Inc
2020/07/3005:30PR Newswire (US)Synthetic Biologics to Report 2020 Second Quarter Operational Highlights and Financial Results on August 6, 2020AMEX:SYNSynthetic Biologics Inc
2020/06/3020:00PR Newswire (US)Synthetic Biologics Announces Submission of IND Application to U.S. FDA for SYN-020 Intestinal Alkaline PhosphataseAMEX:SYNSynthetic Biologics Inc
2020/05/2720:00PR Newswire (US)Synthetic Biologics Enters into Exclusive Option to License Intellectual Property for Use of SYN-020 to Treat and Prevent Age...AMEX:SYNSynthetic Biologics Inc
2020/05/0605:39Edgar (US Regulatory)Quarterly Report (10-q)AMEX:SYNSynthetic Biologics Inc
2020/05/0605:16Edgar (US Regulatory)Current Report Filing (8-k)AMEX:SYNSynthetic Biologics Inc
2020/05/0605:15PR Newswire (US)Synthetic Biologics Reports 2020 First Quarter Operational Highlights and Financial ResultsAMEX:SYNSynthetic Biologics Inc
2020/04/2905:30PR Newswire (US)Synthetic Biologics to Report 2020 First Quarter Operational Highlights and Financial Results on May 5, 2020AMEX:SYNSynthetic Biologics Inc
2020/02/2106:38Edgar (US Regulatory)Annual Report (10-k)AMEX:SYNSynthetic Biologics Inc
 검색 관련기사 보기:AMEX:SYN